SEXUAL FUNCTION AFTER HYPOFRACTIONATED VERSUS CONVENTIONALLY FRACTIONATED RADIOTHERAPY FOR PROSTATE CANCER: RESULTS OF THE PROSPECTIVE, RANDOMIZED PHASE 3 HYPRO TRIAL

被引：1
|
作者：
Wortel, Ruud
Incrocci, Luca
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.321
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP47-02
引用
收藏
页码：E626 / E627
页数：2
相关论文
共 50 条
  • [31] PROSTATE SBRT BOOST RADIOTHERAPY (PBS TRIAL): A RANDOMIZED PHASE II TRIAL OF SBRT VERSUS CONVENTIONALLY-FRACTIONATED RADIOTHERAPY BOOST FOLLOWING PELVIC RADIOTHERAPY IN HIGH-RISK PROSTATE CANCER
    Mesci, Aruz
    Isfahanian, Naghmeh
    Douvi, Georgia
    Gouran-Savadkoohi, Mohammad
    Dayes, Ian
    Lukka, Himanshu
    Quan, Kimmen
    Schnarr, Kara
    Goldberg, Mira
    Hallock, Abhirami
    Chow, Tom
    Diamond, Kevin
    Jakubovic, Raphael
    Thabane, Lahane
    Tsakiridis, Theodoros
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S64 - S64
  • [32] Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trials
    Glicksman, Rachel M.
    Loblaw, Andrew
    Morton, Gerard
    Vesprini, Danny
    Szumacher, Ewa
    Chung, Hans T.
    Chu, William
    Liu, Stanley K.
    Tseng, Chia-Lin
    Davidson, Melanie
    Deabreu, Andrea
    Mamedov, Alexandre
    Zhang, Liying
    Cheung, Patrick
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 49
  • [33] Ultrahypofractionated vs. Moderately Hypofractionated and Conventionally Fractionated Pelvic Radiotherapy for Prostate Cancer: Outcomes from 3 Prospective Clinical Trials
    Glicksman, R.
    Loblaw, D. A.
    Morton, G.
    Vesprini, D.
    Szumacher, E.
    Chung, H. T.
    Chu, W.
    Liu, S. K.
    Tseng, C. L.
    Davidson, M.
    Deabreu, A.
    Mamedov, A.
    Zhang, L.
    Cheung, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E554 - E555
  • [34] Hypo Versus Conventionally Fractionated 30CRT for High Risk Prostate Cancer: Updated Results of a Randomized Trial
    Saracino, B.
    Arcangeli, G.
    Strigari, L.
    Petrongari, M.
    Gomellini, S.
    Giordano, C.
    Ferraro, A.
    Landoni, V.
    Sanguineti, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S53 - S53
  • [35] Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial
    Lucas C. Mendez
    Andrew J. Arifin
    Glenn S. Bauman
    Vikram M. Velker
    Belal Ahmad
    Michael Lock
    Varagur M. Venkatesan
    Tracy L. Sexton
    George B. Rodrigues
    Jeff Chen
    Bryan Schaly
    Andrew Warner
    David P. D’Souza
    BMC Cancer, 20
  • [36] Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial
    Mendez, Lucas C.
    Arifin, Andrew J.
    Bauman, Glenn S.
    Velker, Vikram M.
    Ahmad, Belal
    Lock, Michael
    Venkatesan, Varagur M.
    Sexton, Tracy L.
    Rodrigues, George B.
    Chen, Jeff
    Schaly, Bryan
    Warner, Andrew
    D'Souza, David P.
    BMC CANCER, 2020, 20 (01)
  • [37] Hypofractionated, Dose-Escalated Radiation vs. Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase 3, Prospective, Randomized Controlled Trial
    Hassanzadeh, C. J.
    Kuban, D. A.
    Pasyar, S.
    Bassett, R., Jr.
    Troncoso, P.
    Ansari, M. A.
    Schlembach, P. J.
    McGuire, S. E.
    Nguyen, Q. N.
    Frank, S. J.
    Mok, H.
    Mohamad, O.
    Park, R. J. H.
    Shah, S. J.
    Mayo, L. L.
    Tang, C.
    Du, W.
    Kudchadker, R.
    Choi, S.
    Hoffman, K. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S56 - S56
  • [38] Stereotactic Body Proton Therapy Versus Conventionally Fractionated Proton Therapy for Early Prostate Cancer: A Randomized, Controlled, Phase 3 Trial
    Toesca, Diego A. S.
    Hartsell, William F.
    Dewees, Todd A.
    Chang, John H.
    Laughlin, Brady S.
    Voss, Molly M.
    Dodoo, Christopher A.
    Mohammed, Nasiruddin
    Keole, Sameer R.
    Mcgee, Lisa A.
    Gondi, Vinai
    Sweeney, Patrick J.
    Dorn, Paige
    Sinesi, Christopher C.
    Doh, Lucius S.
    Rich, Tyvin
    Vargas, Carlos E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (05): : 1377 - 1385
  • [39] Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
    Widmark, Anders
    Gunnlaugsson, Adalsteinn
    Beckman, Lars
    Thellenberg-Karlsson, Camilla
    Hoyer, Morten
    Lagerlund, Magnus
    Kindblom, Jon
    Ginman, Claes
    Johansson, Bengt
    Bjornlinger, Kirsten
    Seke, Mihajl
    Agrup, Mans
    Fransson, Per
    Tavelin, Bjorn
    Norman, David
    Zackrisson, Bjorn
    Anderson, Harald
    Kjellen, Elisabeth
    Franzen, Lars
    Nilsson, Per
    LANCET, 2019, 394 (10196): : 385 - 395
  • [40] Hypo-Fractionated Versus Conventionally Fractionated Radiotherapy for Patients with LS-SCLC: An Open-Label, Randomized, Phase 3 Trial
    Bi, N.
    Hu, X.
    Zhao, K.
    Yang, Y.
    Zhang, L.
    E, M.
    Cao, J.
    Ge, H.
    Zhu, X.
    Zhao, L.
    Di, Y.
    Jiang, W.
    Ran, J.
    Zhang, H.
    Zhang, T.
    Shen, W.
    Deng, C.
    Hu, C.
    Chen, M.
    Wang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1190 - S1191
12345